Unfortunately, that's biotech.
Some biotech drop 90% even after phase 3, at the final stage when FDA reject their application, e.g. BOT, MSB
They they came back to get approval and the SP went back up (but still below IPO).
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-31
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.39M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 43.0¢ | 39.0¢ | $102.0K | 248.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 352 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 1500 | 1 |
View Market Depth
| Last trade - 15.44pm 30/08/2024 (20 minute delay) ? |
| TRP (ASX) Chart |